5 Reksa Dana Terbaik dengan TRAW / Traws Pharma, Inc. (NasdaqCM)

Traws Pharma, Inc.

US ˙ NasdaqCM

5 Reksa Dana Terbaik dengan TRAW / Traws Pharma, Inc.

Halaman ini menampilkan semua reksa dana yang telah melaporkan posisi di TRAW / Traws Pharma, Inc.. Baris berwarna hijau menunjukkan posisi baru. Klik tautan ikon untuk melihat riwayat transaksi selengkapnya.

Tingkatkan ke versi premium untuk membuka data premium dan ekspor ke Excel. .

Tanggal File	Sumber	Investor		Ketik	Presyo ng Avg (Silangan)	Saham	Δ Saham (%)	Dilaporkan Nilai ($1000)	Nilai Δ (%)	Alokasi Port (%)
2025-08-27	NP	VEXMX - Vanguard Extended Market Index Fund Investor Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				12,911	0.00	19	-34.48
2025-07-24	NP	FCFMX - Fidelity Series Total Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				5,859	62.39	8	-27.27
2025-07-24	NP	FSKAX - Fidelity Total Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				7,466	0.00	11	-58.33
2025-07-24	NP	FNCMX - Fidelity Nasdaq Composite Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				743	-39.40	1	-75.00
2025-07-24	NP	FSMAX - Fidelity Extended Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				16,850	26.88	24	-46.51

Other Listings

DE:0T20

Fintel data has been cited in the following publications:

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.